ING Group’s Novavax NVAX Stock Holding History

ING Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,800	Closed	-$26.3K	–	641
2023 Q1	$26.3K	Buy	+3,800	New	+$35K	﹤0.01%	602
2022 Q2	–	Sell	-3,800	Closed	-$280K	–	560
2022 Q1	$280K	Buy	+3,800	New	+$339K	﹤0.01%	509
2019 Q1	–	Sell	-1,250	Closed	-$46K	–	786
2018 Q4	$46K	Hold	1,250	–	–	﹤0.01%	690
2018 Q3	$47K	Buy	+1,250	New	+$35.2K	﹤0.01%	761
2017 Q3	–	Sell	-1,000	Closed	-$23K	–	880
2017 Q2	$23K	Hold	1,000	–	–	﹤0.01%	824
2017 Q1	$26K	Hold	1,000	–	–	﹤0.01%	567
2016 Q4	$26K	Hold	1,000	–	–	﹤0.01%	529
2016 Q3	$41K	Buy	+1,000	New	+$129K	﹤0.01%	563

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ING Group's NVAX Position: Q2 2023 in Review

ING Group sold out of Novavax (NVAX) in Q2 2023, closing a stake of 3,800 shares — an estimated $26.3K sold.

ING Group first reported a position in NVAX in Q3 2016 and held it in 8 quarters. The position peaked at $280K in Q1 2022. 215 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

ING Group reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
ING Group sold 3,800 Novavax shares in Q2 2023, an estimated $26.3K.
ING Group first reported a position in Novavax in Q3 2016 and held it in 8 quarters.
ING Group's Novavax position peaked at $280K in Q1 2022.
215 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on ING Group's 13F filing for Q2 2023, filed 7 Aug 2023.